EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

LTB ‐ TREAT : A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma

Luani Barge, Lachlan Webb iD, Anita Pelecanos, Niamh Waters iD, Ross Salvaris iD, Sam Lai, Tessa Potezny, Helen Cashman, Caitlyn Nguyen-Ngo, Denise Lee, Costas K Yannakou, Nada Hamad iD und 14 weitere

British Journal of Haematology · 2026-10 · 209 (4) · 1673-1683

DOI: 10.1111/bjh.70748 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift British Journal of Haematology, online erschienen am 27.08.2026. Verfasst von Luani Barge und 25 weiteren Autor:innen. Beteiligte Einrichtung: Princess Alexandra Hospital, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Lymphoma, Follicular, Time-to-Treatment, Watchful Waiting. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Watchful waiting (WW) in low tumour burden follicular lymphoma (LTB FL) defers treatment. There is a need to develop a model to predict time to treatment (TTT). We aimed to develop and externally validate a model for TTT in LTB FL. We conducted a retrospective analysis across eight centres within the Australasian Lymphoma Alliance. Two hundred and twenty‐nine patients were included between 2004 and 2022 with a median follow‐up of 5.0 years (range 0.5–17.8 years) and a median age was 64 years. All patients were Group d'Etude des Lymphomes Folliculaires (GELF) negative and managed with WW. Elevated lactate dehydrogenase and >4 nodal areas were independent prognostic factors associated with shorter TTT. These factors formed a prognostic model identifying three groups: low 59% (median TTT 6.34 years), intermediate 36% (median TTT 4.08 years), high risk 5% (median TTT 1.49 years) ( p < 0.001). There was a higher incidence of serious complications among risk groups (low 7.5% vs. intermediate 13.3% vs. high 25%; p = 0.096). The prognostic value of the LTB‐TREAT model was confirmed in an external validation cohort. The low‐risk group is predicted to have a prolonged TTT with WW and a high‐risk group is predicted to experience early progression in whom treatment should be considered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, FollicularTime-to-TreatmentWatchful WaitingHumansFemalePrognosisRetrospective StudiesMiddle AgedMaleAgedTumor BurdenAged, 80 and overAdult

Stichwörter der Autor:innen

low tumour burden follicular lymphomaprognostic modelstime to treatment

Autor:innen und Institutionen

  • Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • School of Medicine, University of Queensland, Brisbane, Queensland, Australia.
  • QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Olivia Newton John Cancer Research Institute at Austin Hospital, Melbourne, Victoria, Australia.
  • Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
  • Westmead Hospital, Sydney, New South Wales, Australia.

ORCID-Profile: Lachlan Webb, Niamh Waters, Ross Salvaris, Nada Hamad, Sylvain Choquet, Lukshe Kanagaratnam, Chan Y Cheah, Eliza A Hawkes, Kirk Morris, Eric Durot, Greg Hapgood

Zitieren

APA

Barge, L., Webb, L., Pelecanos, A., Waters, N., Salvaris, R., Lai, S., Potezny, T., Cashman, H., Nguyen-Ngo, C., Lee, D., Yannakou, C. K., Hamad, N., Chauchet, A., Choquet, S., Rossi, C., Herbin, A., Kanagaratnam, L., Rodier, C., Tam, C. S., …, & Hapgood, G. (2026). LTB ‐ TREAT : A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma. British Journal of Haematology, 209(4), 1673-1683. https://doi.org/10.1111/bjh.70748

Vancouver

Barge L, Webb L, Pelecanos A, Waters N, Salvaris R, Lai S, et al. LTB ‐ TREAT : A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma. British Journal of Haematology. 2026;209(4):1673-1683. doi:10.1111/bjh.70748

BibTeX
@article{Barge2026,
  author = {Barge, Luani and Webb, Lachlan and Pelecanos, Anita and Waters, Niamh and Salvaris, Ross and Lai, Sam and Potezny, Tessa and Cashman, Helen and Nguyen-Ngo, Caitlyn and Lee, Denise and Yannakou, Costas K and Hamad, Nada and Chauchet, Adrien and Choquet, Sylvain and Rossi, Cédric and Herbin, Adélie and Kanagaratnam, Lukshe and Rodier, Cyrielle and Tam, Constantine S and Bhattacharyya, Abir and Cheah, Chan Y and Hawkes, Eliza A and Morris, Kirk and Durot, Eric and Tobin, Joshua and Hapgood, Greg},
  title = {LTB ‐ TREAT : A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {209},
  number = {4},
  pages = {1673--1683},
  doi = {10.1111/bjh.70748}
}
Kostenlos starten →